Refine
Year of publication
Document Type
- Preprint (686)
- Article (497)
- Conference Proceeding (2)
- Book (1)
- Other (1)
Has Fulltext
- yes (1187)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- Mammakarzinom (6)
- breast cancer (6)
- ALICE experiment (4)
- Behandlung (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Studien (4)
- trials (4)
- ALICE (3)
- COVID-19 (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- chemotherapy (3)
- pp collisions (3)
- Antimicrobial treatment (2)
- Atomic force microscopy (2)
- Beauty production (2)
- Biofilm (2)
- Brownian dynamics simulation (2)
- CDK4/6 (2)
- Cancer genomics (2)
- Charm physics (2)
- Complications (2)
- Deep brain stimulation (2)
- Diagnostik (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Galaktografie (2)
- Galaktomosynthese (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Lokalrezidiv (2)
- Low-virulent infection (2)
- MRI (2)
- MRT (2)
- Mamma (2)
- Metastasen (2)
- Molecular dynamics simulation (2)
- Nachsorge (2)
- PD1/PDL1 (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Prognosefaktoren (2)
- Prädiktivfaktoren (2)
- Prävention (2)
- QCD (2)
- Relativistic heavy-ion collisions (2)
- Richtlinie (2)
- Risiko (2)
- Single electrons (2)
- Single molecule force spectroscopy (2)
- Sonication (2)
- Tomosynthese (2)
- Ultraschall (2)
- biodiversity protection (2)
- breast (2)
- conservation funding (2)
- conservation planning (2)
- decision making (2)
- diagnosis (2)
- follow‑up (2)
- galactography (2)
- galactomosynthesis (2)
- global change (2)
- guideline (2)
- immune reconstitution (2)
- local recurrence (2)
- long non-coding RNA (2)
- macrophage polarization (2)
- malignancy (2)
- post-2020 biodiversity targets (2)
- predictive factors (2)
- prevention (2)
- primary immunodeficiency (2)
- prognostic factors (2)
- risk (2)
- screening (2)
- strategic site selection (2)
- tomosynthesis (2)
- treatment (2)
- treatment/therapy (2)
- ultrasound (2)
- von Willebrand factor (2)
- 900 GeV (1)
- ADAM15 (1)
- ALICE detector (1)
- ARDS (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Air traffic (1)
- Allogeneic hematopoietic stem (1)
- Anandamide (1)
- Anti-nuclei (1)
- Antihormone therapy (1)
- Aquaporins (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Ataxia-telangiectasia (1)
- Atherosclerosis (1)
- Auditory system (1)
- BTC (1)
- Bacteria-host interaction (1)
- Bacterial adhesion (1)
- Bidirectional genes (1)
- Biodiversity Data (1)
- Biomonitoring (1)
- Bone conduction devices (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Bromodomänen (1)
- CCL2 (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- COVID (1)
- CRISPR/Cas9 (1)
- CVD biomarker (1)
- CYBA/p22phox (1)
- Cancer (1)
- Cancer genetics (1)
- Cardiomyopathy (1)
- Cardiovascular diseases (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Chemische Sonden (1)
- Chimerism (1)
- Cleanliness level (1)
- Clinical study (1)
- Clinical trial (1)
- Collective Flow, (1)
- Colon capsule endoscopy (1)
- Colorectal cancer (1)
- Comparison with QCD (1)
- Complementation rate (1)
- Complex I (1)
- Consensus statement (1)
- Conservation (1)
- Critical care (1)
- Depression (1)
- Desinfektion von Flugzeugen (1)
- Diatoms (1)
- Digitization (1)
- Disinfection of aircraft (1)
- D’Amico classification (1)
- E/I-Balance (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Embryotoxicity (1)
- Emotions (1)
- Endometrial cancer (1)
- Endothelium (1)
- Epigenetics (1)
- Epigenetik (1)
- Europe (1)
- Experimental models of disease (1)
- Extracellular matrix (1)
- Falciparum (1)
- FcpA (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Fibronectin (1)
- Forschung (1)
- GVHD (1)
- Gamma-Band Activity (1)
- Gene expression (1)
- Genetic testing (1)
- Genomic instability (1)
- Germany (1)
- Gleason score (1)
- Glioblastoma (1)
- HBT (1)
- HDAC4 (1)
- HER2 c-erbB2 (1)
- HER2/neu (1)
- HNO (1)
- HOTAIR (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hand-foot syndrome (1)
- Hard Scattering (1)
- Health policy (1)
- Health risk analysis (1)
- Heart transplantation (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Herbaria (1)
- Heregulin (1)
- Hif1α (1)
- Highly infectious diseases (1)
- His-tag (1)
- Hochansteckende Krankheiten (1)
- Human behaviour (1)
- Human prostate (1)
- Inclusive spectra (1)
- Incomplete colonoscopy (1)
- Inflammation (1)
- Influenza (1)
- Intensity interferometry (1)
- Intestinal barrier (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Italy (1)
- JAWSTAT pathway (1)
- Jet Physics (1)
- Jet Substructure (1)
- KCNQ4 (1)
- LHRH receptor (1)
- Lactic acidosis (1)
- Lehre (1)
- Liver cirrhosis (1)
- Low volume prep (1)
- Luftverkehr (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- MALAT1 (1)
- MGMT (1)
- MM-121 (1)
- Malaria (1)
- Material budget (1)
- Medizinische Chemie (1)
- Membrane protein (1)
- Mental health and psychiatry (1)
- Mesenchymal stem cells (1)
- Metastatic (1)
- Mid-rapidity (1)
- Minimal residual disease (1)
- Minimum Bias (1)
- Mitochondrial disorder (1)
- Mixed hearing loss (1)
- Molecular medicine (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-Parton Interactions (1)
- Multi-endpoint toxicity study (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Myocardial infarction (1)
- N-methyl-D-aspartate receptor (1)
- NADPH oxidase (1)
- NCoR1 (1)
- NK cell (1)
- NK cell subset (1)
- NSAIDs (1)
- Nano- and microplastics (1)
- Nanodisc (1)
- Neonatal (1)
- Neural network (1)
- Neuroscience (1)
- Nuclear modification factor (1)
- ORL (1)
- Obesity (1)
- Oncology (1)
- Otorhinolaryngology (1)
- Outcome (1)
- PD-1 (1)
- PD-L1 (1)
- PDGFRβ (1)
- PYTHIA (1)
- Parainfluenza (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Phase 2 (1)
- Phospho-soda (1)
- PillCamColon2 (1)
- Placental barrier (1)
- Plasmodium (1)
- Pneumonia (1)
- Polyps (1)
- Polystyrene (1)
- Portal hypertension (1)
- Pre-emptive immunotherapy (1)
- Primary hemostasis (1)
- Primary prophylaxis (1)
- Production Cross Section (1)
- Produkte zur Desinfektion (1)
- Prognosis (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostate cancer (1)
- Prostate cancer cell lines (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- Psychometrics (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Questionnaires (1)
- Quinine (1)
- RNA PT (1)
- RNA modification (1)
- Rapidity Range (1)
- Red blood cell transfusion (1)
- Rehabilitation (1)
- Relativistic heavy ion physics (1)
- Research (1)
- Research Article (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Resonance assignment (1)
- Respiratory syncytial virus (1)
- Rheumatoid arthritis (1)
- Rheumatology (1)
- SARS-CoV-2 (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SCT (1)
- SIRT1 (1)
- SNP (1)
- STAT3 (1)
- SUV (1)
- Schizophrenia (1)
- Semantics (1)
- Seribantumab (1)
- Severe malaria (1)
- Single muons (1)
- Single-cell RNA-seq (1)
- Solution-state NMR (1)
- Sorafenib (1)
- Specialist training (1)
- Spontaneous bacterial peritonitis (1)
- Standardized operating procedures (1)
- Standardverfahren (1)
- Stroke (1)
- Strukturbasiertes Design (1)
- Substances for disinfection (1)
- Superinfection (1)
- Surgery (1)
- Sweden (1)
- Systematic Uncertainty (1)
- T-DM1 (1)
- TR (1)
- TRPV4 (1)
- Targeted therapy (1)
- Taxonomy (1)
- Teaching (1)
- Technical data (1)
- Temozolomide (1)
- Thrombosis (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Treatment (1)
- Trigger (1)
- University hospitals (1)
- Universitätskliniken (1)
- Upper respiratory tract infection (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Vector Boson Production (1)
- Vitamin (1)
- Weiterbildung (1)
- Xenon-based gas mixture (1)
- accident (1)
- adult (1)
- advanced breast cancer (1)
- agaricomycetes (1)
- allogeneic stem cell transplantation (1)
- anaemia (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- anti-angiogenic therapy (1)
- antifungals (1)
- antihormone therapy (1)
- ataxia telangiectasia (1)
- biodiversity (1)
- biologicals (1)
- bortezomib (1)
- brain metastases (1)
- bromodomains (1)
- c-kit (1)
- cancer (1)
- cancer surveillance (1)
- cascade model (1)
- cell proliferation (1)
- cell transplantation (1)
- cerebrospinal fluid (1)
- chemical probes (1)
- children (1)
- clinical trial (1)
- cochlea (1)
- combined immunodeficiency (1)
- community ecology (1)
- cross-linking (1)
- dE/dx (1)
- dental implants (1)
- detector (1)
- digestion artifact (1)
- discomfort/pain (1)
- dynamic 18F-FDG PET/CT (1)
- ecological networks (1)
- ecosystem functioning (1)
- ecosystem services (1)
- elderly patients (1)
- epigenetics (1)
- experimental results (1)
- functional connectivity (1)
- geriatric medicine (1)
- glioblastoma (1)
- heavy ion experiments (1)
- human (1)
- human knockout model (1)
- human well-being (1)
- induction regimen (1)
- injury (1)
- inverse stage migration (1)
- iron metabolism (1)
- kidney (1)
- kidney function (1)
- knockout mouse (1)
- lapatinib (1)
- lenalidomide (1)
- leukopenia (1)
- lockdown (1)
- long-term protection (1)
- long36 term protection (1)
- magnetic resonance imaging (1)
- magnetoencephalography (1)
- mass spectrometry (1)
- mechanotransduction (1)
- medicinal chemistry (1)
- medulloblastoma (1)
- metastases (1)
- metastasis (1)
- metastatic (1)
- multiple myeloma (1)
- neural oscillations (1)
- neutralizing antibodies (1)
- neutropenia (1)
- nucleoside analysis (1)
- pancreatic cancer (1)
- pannexin-1 (1)
- pazopanib (1)
- pediatric intensive care (1)
- periodontal probing, (1)
- peri‐implant probing (1)
- pertuzumab (1)
- photosynthesis (1)
- platform switching (1)
- polyacetylenes (1)
- polyines (1)
- polymeric micelle (1)
- polymorphism (1)
- polypept(o)ide (1)
- polyynes (1)
- pre-emptive allogeneic hematopoietic stem cell transplantation (1)
- prognosis (1)
- prostate cancer (1)
- quark gluon plasma (1)
- radical prostatecomy (1)
- radio sensitivity (1)
- radiotherapy (1)
- randomized (1)
- renal failure (1)
- risk factor progression (1)
- risk factors (1)
- schizophrenia (1)
- social-ecological system (1)
- soft tissue sarcoma (STS) (1)
- species identity (1)
- spectra (1)
- spike protein (1)
- stroke (1)
- structure-based design (1)
- subgrouping (1)
- superparamagnetic iron oxide nanoparticles (1)
- surgery (1)
- targeted therapy (1)
- therapy resistance (1)
- thylakoid (1)
- trastuzumab (1)
- trauma (1)
- tumor angiogenesis (1)
- tumor-infiltrating lymphocytes (1)
- two-tissue compartment model (1)
- variants of concern (1)
- xenograft (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1077)
- Frankfurt Institute for Advanced Studies (FIAS) (960)
- Informatik (924)
- Medizin (79)
- Biowissenschaften (11)
- Senckenbergische Naturforschende Gesellschaft (6)
- Biochemie und Chemie (4)
- Pharmazie (4)
- Georg-Speyer-Haus (3)
- Informatik und Mathematik (3)
The establishment and maintenance of protected areas(PAs) is viewed as a key action in delivering post-2020 biodiversity targets. PAs often need to meet a multitude of objectives, ranging from biodiversity protection to ecosystem service provision and climate change mitigation. As available land and conservation funding are limited, optimizing resources by selecting the most beneficial PAs is vital. Here we present a decision support tool that enables a flexible approach to PA selection on a global scale, allowing different conservation objectives to be weighted and prioritized according to user-specified preferences. We apply the tool across 1347 terrestrial PAs and highlight frequent trade-offs among different objectives, e.g., between biodiversity protection and ecosystem integrity. These results indicate that decision makers must usually decide among conflicting objectives. To assist this our decision support tool provides an explicitly value-based approach that can help resolve such conflicts by considering divergent societal and political demands and values.
We report on posttransplant relapsed pediatric patients with B-precursor acute lymphoblastic leukemia with no further standard of care therapy who were treated with the T-cell engaging CD19/CD3-bispecific single-chain antibody construct blinatumomab on a compassionate use basis. Blast load was assessed prior to, during and after blinatumomab cycle using flow cytometry to detect minimal residual disease, quantitative polymerase chain reaction for rearrangements of the immunoglobulin or T-cell receptor genes, and bcr/abl mutation detection in one patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blinatumomab was administered as a 4-week continuous intravenous infusion at a dosage of 5 or 15 μg/m2/day. Nine patients received a total of 18 cycles. Four patients achieved complete remission after the first cycle of treatment; 2 patients showed a complete remission from the second cycle after previous reduction of blast load by chemotherapy. Three patients did not respond, of whom one patient proceeded to a second cycle without additional chemotherapy and again did not respond. Four patients were successfully retransplanted in molecular remission from haploidentical donors. After a median follow up of 398 days, the probability of hematologic event-free survival is 30%. Major toxicities were grade 3 seizures in one patient and grade 3 cytokine release syndrome in 2 patients. Blinatumomab can induce molecular remission in pediatric patients with posttransplant relapsed B-precursor acute lymphoblastic leukemia and facilitate subsequent allogeneic hematopoietic stem cell transplantation from haploidentical donor with subsequent long-term leukemia-free survival.
For infectious diseases caused by highly pathogenic agents (e. g., Ebola/Lassa fever virus, SARS-/MERS-CoV, pandemic influenza virus) which have the potential to spread over several continents within only a few days, international Health Protection Authorities have taken appropriate measures to limit the consequences of a possible spread. A crucial point in this context is the disinfection of an aircraft that had a passenger on board who is suspected of being infected with one of the mentioned diseases. Although, basic advice on hygiene and sanitation on board an aircraft is given by the World Health Organization, these guidelines lack details on available and effective substances as well as standardized operating procedures (SOP). The purpose of this paper is to give guidance on the choice of substances that were tested by a laboratory of Lufthansa Technik and found compatible with aircraft components, as well as to describe procedures which ensure a safe and efficient disinfection of civil aircrafts. This guidance and the additional SOPs are made public and are available as mentioned in this paper.
We investigate the early time dynamics of heavy ion collisions studying the time evolution of the energy-momentum tensor as well as energy-momentum correlations within a uniformly thermalizing holographic QGP. From these quantities, we suggest a far-from equilibrium definition of shear viscosity, which is a crucial property of QCD matter as it significantly determines the generation of elliptic flow already at early times. During an exemplary initial heating phase of the holographic QGP the shear viscosity of entropy density ratio decreases down to 60%, followed by an overshoot to 110% of the near-equilibrium value, η/s=1/(4π). Implications for the QCD QGP are discussed. Subsequently, we consider a holographic QGP which is Bjorken-expanding. Its energy-momentum tensor components have a known hydrodynamic attractor to which all time evolutions collapse independent of the initial conditions. Based on this, we propose a definition for a far from equilibrium speed of sound, and analytically compute its hydrodynamic attractor. Subjecting this Bjorken-expanding plasma to an external magnetic field and an axial chemical potential, we study the chiral magnetic effect far from equilibrium.
It is widely acknowledged that biodiversity change is affecting human well-being by altering the supply of Nature's Contributions to People (NCP). Nevertheless, the role of individual species in this relationship remains obscure. In this article, we present a framework that combines the cascade model from ecosystem services research with network theory from community ecology. This allows us to quantitatively link NCP demanded by people to the networks of interacting species that underpin them. We show that this “network cascade” framework can reveal the number, identity and importance of the individual species that drive NCP and of the environmental conditions that support them. This information is highly valuable in demonstrating the importance of biodiversity in supporting human well-being and can help inform the management of biodiversity in social-ecological systems.
We investigate the early time dynamics of heavy ion collisions studying the time evolution of the energy-momentum tensor as well as energy-momentum correlations within a uniformly thermalizing holographic QGP. From these quantities, we suggest a far-from equilibrium definition of shear viscosity, which is a crucial property of QCD matter as it significantly determines the generation of elliptic flow already at early times. During an exemplary initial heating phase of the holographic QGP the shear viscosity of entropy density ratio decreases down to 60%, followed by an overshoot to 110% of the near-equilibrium value, η/s=1/(4π). Implications for the QCD QGP are discussed. Subsequently, we consider a holographic QGP which is Bjorken-expanding. Its energy-momentum tensor components have a known hydrodynamic attractor to which all time evolutions collapse independent of the initial conditions. Based on this, we propose a definition for a far from equilibrium speed of sound, and analytically compute its hydrodynamic attractor. Subjecting this Bjorken-expanding plasma to an external magnetic field and an axial chemical potential, we study the chiral magnetic effect far from equilibrium.
TRIANNI mice carry an entire set of human immunoglobulin V region gene segments and are a powerful tool to rapidly isolate human monoclonal antibodies. After immunizing these mice with DNA encoding the spike protein of SARS-CoV-2 and boosting with spike protein, we identified 29 hybridoma antibodies that reacted with the SARS-CoV-2 spike protein. Nine antibodies neutralize SARS-CoV-2 infection at IC50 values in the subnanomolar range. ELISA-binding studies and DNA sequence analyses revealed one cluster of three clonally related neutralizing antibodies that target the receptor-binding domain and compete with the cellular receptor hACE2. A second cluster of six clonally related neutralizing antibodies bind to the N-terminal domain of the spike protein without competing with the binding of hACE2 or cluster 1 antibodies. SARS-CoV-2 mutants selected for resistance to an antibody from one cluster are still neutralized by an antibody from the other cluster. Antibodies from both clusters markedly reduced viral spread in mice transgenic for human ACE2 and protected the animals from SARS-CoV-2-induced weight loss. The two clusters of potent noncompeting SARS-CoV-2 neutralizing antibodies provide potential candidates for therapy and prophylaxis of COVID-19. The study further supports transgenic animals with a human immunoglobulin gene repertoire as a powerful platform in pandemic preparedness initiatives.